Thursday, April 7, 2011

Testing Alterations In Night Vision

Error in deserializing body of reply message for operation 'Translate'. The maximum string content length quota (8192) has been exceeded while reading XML data. This quota may be increased by changing the MaxStringContentLength property on the XmlDictionaryReaderQuotas object used when creating the XML reader. Line 1, position 8760.

Main Category: Eye Health / Blindness
Also Included In: IT / Internet / E-mail;  Medical Devices / Diagnostics
Article Date: 25 Mar 2011 - 2:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Researchers from the Department of Optics of the University of Granada, belonging to the Laboratorio de Ciencias de la Vision y Aplicaciones, have developed a programme for testing alterations in night vision, and the tool required to implement it, which has been named "halometer".

This instrument consists of software named Software Halo v1.0, and a computer where the mouse is used as a response button, and a chin cup with a forehead holder to fix the observer's position. Software Halo v1.0 was initially presented as freeware available on LabVisGra's website and at the University of Granada's institutional repository. Nevertheless, it was recently released by the Free-Software Bureau of the University of Granada so, it has become a scientific freeware application.

This software was developed by a group coordinated by Rosario González Anera, receiving technical support of the Granadian company Seven Solutions and of an ophthalmological clinic set in Madrid and named Novovision. The research group was integrated by researchers José Juan Castro, Carolina Ortiz and Aixa Alarcón, and receives fundings from the regional government of Economy, Innovation and Science of the Junta de Andalucía.

Low-Light Conditions

Before the test, researchers fix the observer's position with a chin cup and a forehead holder at an adequate distance from the monitor where the test will be displayed and considering the angular diameter that light stimuli must have. The test is performed under low-light conditions (in a dark room) and, before the test, patients are given some minutes to adapt to darkness.

This test involves showing a bright light stimulus to the subject against a dark background and, progessively showing different peripheral light stimuli - with lower brightness around the central, at random, in different positions and at different distances. Subjects' task is to press the buttom of a mouse every time they detect a peripheral stimulus. Once the test ends, the software makes an estimation of a parameter named "Visual Disturbance Index" that, together with the results graphic, determines the type and intensity of visual disturbance.

This index scores from 0 to 1, so the higher is this index, the stronger is the influence of the halo or any other visual disturbance perceived by the observer. Therefore, the lower is the subject's ability to detect the peripheral stimuli displayed around the main stimulus that causes such disturbances.

One of the advantages of the halometer developed at the University of Granada is that it allows to configure such test parameters as: Special parameters: the radius of the central stimulus and the peripheral stimuli can be modified. Furthermore, the number of semi-major axes where the peripheral stimuli will be displayed can be fixed, as well as the maximum radius - maximum distance between these stimuli-, and the number of stimuli per semi-major axe. Temporary Parameters: the software allows to set some exposure time for adaptation to darkness and to the brightness of the central stimulus. Furthermore, others parameters as the exposure time to the stimulus and the time elapsed between a stimulus and the next one can also be set. The software also allows to set the color and brightness of central and peripheral stimuli, and the weight and number of times each peripheral stimulus is shown. This test has been tried with different observer groups consisting of people operated on cataract or submitted to refractary eye surgery, with normal observers and patients with different eye pathologies as AMD (Age-related Macular Degeneration) and unilateral keratitis. The results obtained showed that, in the case of patients with keratitis, the visual disturbance index for the healthy eye was found to be lower than that for the unhealthy eye, and even lower under binocular vision conditions. However, visual disturbance indexes proved to be higher in the case of patients operated on cataracts, showing a higher influence of halos and, therefore, lower detection capacity. Patients operated with LASIK refractory eye surgery also presented high vision disturbance indexes in comparison to normal observers. The results obtained with this halometer and the new software have been presented in different national and international conferences as the IX Reunión Nacional de Optica, Galice and the Wavefront Confress 2009. Furthermore, a research article has been published in the international journal Applied Optics describing the results obtained with patients operated on for refractory eye surgery. It has also been recently admitted for publication in the prestigious scientific journal Journal of Biomedical Optics, where the results obtained with patients with different eye pathologies are described.

This press release is available in French and Spanish.

Source:
José Juan Castro
University of Granada

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

No comments:

Post a Comment